Variant report
Variant | esv3359306 |
---|---|
Chromosome Location | chr15:50508110-50510058 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr15:50509820-50509970 | GM12873 | blood: | n/a | n/a |
2 | CTCF | chr15:50509820-50509970 | GM12875 | blood: | n/a | n/a |
3 | CTCF | chr15:50508479-50508557 | GM10248 | blood: | n/a | n/a |
4 | CTCF | chr15:50509800-50509950 | GM12872 | blood: | n/a | n/a |
5 | CTCF | chr15:50509760-50509910 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr15:50509840-50509990 | BE2_C | brain: | n/a | n/a |
7 | FOXA1 | chr15:50507988-50508291 | T-47D | breast: | n/a | n/a |
8 | FOXA1 | chr15:50507908-50508386 | T-47D | breast: | n/a | n/a |
9 | GATA3 | chr15:50507875-50508305 | T-47D | breast: | n/a | n/a |
10 | POLR2A | chr15:50509611-50509916 | Hela-S3 | cervix: | n/a | n/a |
11 | POLR2A | chr15:50509774-50509782 | A549 | lung: | n/a | n/a |
12 | TCF7L2 | chr15:50508012-50508196 | MCF-7 | breast: | n/a | n/a |
13 | TCF7L2 | chr15:50509723-50509870 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000200605 | TF binding region |
ENSG00000244879 | chromatin interactions |
ENSG00000104064 | chromatin interactions |
ENSG00000200605 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537350993 | chr15:50508128-50508129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180932426 | chr15:50508182-50508183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569921828 | chr15:50508218-50508219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562877087 | chr15:50508259-50508260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147806167 | chr15:50508305-50508306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148847423 | chr15:50508327-50508328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566358035 | chr15:50508352-50508353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186296863 | chr15:50508391-50508392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548806260 | chr15:50508428-50508429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191536235 | chr15:50508453-50508454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577030872 | chr15:50508458-50508459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567464313 | chr15:50508485-50508486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556375048 | chr15:50508501-50508502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376266869 | chr15:50508527-50508528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571442897 | chr15:50508556-50508557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538575097 | chr15:50508572-50508573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553996406 | chr15:50508707-50508708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201855182 | chr15:50508751-50508752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371273005 | chr15:50508792-50508793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12906728 | chr15:50508799-50508800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12906729 | chr15:50508801-50508802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373827918 | chr15:50508808-50508809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2554882 | chr15:50508809-50508810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113467698 | chr15:50508811-50508812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201608799 | chr15:50508817-50508818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183389137 | chr15:50508830-50508831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59683706 | chr15:50508844-50508845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71124332 | chr15:50508853-50508854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12906490 | chr15:50508856-50508857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12907747 | chr15:50508857-50508858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573161903 | chr15:50508881-50508882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201202390 | chr15:50509035-50509036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200312242 | chr15:50509036-50509037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540619723 | chr15:50509091-50509092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150212940 | chr15:50509145-50509146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188497398 | chr15:50509210-50509211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190509991 | chr15:50509258-50509259 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs28667622 | chr15:50509289-50509290 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs183138879 | chr15:50509302-50509303 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs533534165 | chr15:50509303-50509304 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs74200854 | chr15:50509306-50509307 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs148351224 | chr15:50509309-50509310 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs368930022 | chr15:50509312-50509313 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs375056133 | chr15:50509370-50509371 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs370403790 | chr15:50509384-50509385 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs535995536 | chr15:50509403-50509404 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs28431947 | chr15:50509525-50509526 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs527339446 | chr15:50509548-50509549 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs12913823 | chr15:50509591-50509592 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs187810718 | chr15:50509627-50509628 | Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:50498000-50515200 | Weak transcription | K562 | blood |
2 | chr15:50503200-50514400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr15:50503600-50511800 | Weak transcription | Hela-S3 | cervix |
4 | chr15:50503600-50513400 | Weak transcription | Stomach Mucosa | stomach |
5 | chr15:50503600-50515600 | Weak transcription | A549 | lung |
6 | chr15:50503600-50519800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr15:50503600-50539800 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
8 | chr15:50503800-50515000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
9 | chr15:50504000-50511800 | Weak transcription | Primary hematopoietic stem cells | blood |
10 | chr15:50504400-50512800 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr15:50504800-50512400 | Weak transcription | Liver | Liver |
12 | chr15:50505200-50514400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr15:50505800-50511400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr15:50507800-50508600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
15 | chr15:50508000-50515000 | Weak transcription | HepG2 | liver |
16 | chr15:50508000-50539800 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
17 | chr15:50508600-50513000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |